by Admin Neo Lumina | Feb 9, 2024 | News
Could Mushrooms Be the Drug to Finally Cure Eating Disorders? For young patients, lasting treatment can feel elusive. Psychedelics could change that. The first time Sophia Anderson tripped on psychedelic mushrooms, she was 16 years old. It happened in late 2020, in...
by Admin Neo Lumina | Feb 9, 2024 | News
Psilocybin therapy for end-of-life care supported by 79% of Canadians A new survey has revealed that over 79% of Canadians support psychedelic-assisted therapy for existential distress at the end of life. People facing a terminal diagnosis often experience significant...
by Admin Neo Lumina | Feb 9, 2024 | News
Filament Health Announces FDA Opening Of Investigational New Drug Application For Substance Use Disorders Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to share some groundbreaking news. The U.S. Food and Drug Administration (FDA) has given its...
by Admin Neo Lumina | Jan 19, 2024 | News
Maybe, just maybe, psychedelics are the “master key” for unlocking everything from blindness to stroke to anorexia If I told you psychedelics might help people with everything from depression to blindness to anorexia to autism to stroke, you might think that’s just...
by Admin Neo Lumina | Jan 19, 2024 | News
Vital report explores employment in the psychedelics industry Psychedelics Today recently surveyed students and graduates of its 12-month intensive professional psychedelic certification programme, Vital, publishing its findings in The Emerging Psychedelic Workforce...
by Admin Neo Lumina | Jan 19, 2024 | News
Europe to establish regulatory guidance on psychedelics in 2024 The European Medicines Agency (EMA) is set to hold a multi-stakeholder workshop on medical psychedelics in April 2024 to establish regulatory guidelines for the development and therapeutic use of...
